BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32353589)

  • 21. 18β-glycyrrhetinic acid attenuates anandamide-induced adiposity and high-fat diet induced obesity.
    Park M; Lee JH; Choi JK; Hong YD; Bae IH; Lim KM; Park YH; Ha H
    Mol Nutr Food Res; 2014 Jul; 58(7):1436-46. PubMed ID: 24687644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs.
    Xie X; Liao H; Dang H; Pang W; Guan Y; Wang X; Shyy JY; Zhu Y; Sladek FM
    Mol Endocrinol; 2009 Apr; 23(4):434-43. PubMed ID: 19179483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preservation of hepatocyte nuclear factor-4α contributes to the beneficial effect of dietary medium chain triglyceride on alcohol-induced hepatic lipid dyshomeostasis in rats.
    Li Q; Zhong W; Qiu Y; Kang X; Sun X; Tan X; Zhao Y; Sun X; Jia W; Zhou Z
    Alcohol Clin Exp Res; 2013 Apr; 37(4):587-98. PubMed ID: 23126616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis.
    Hayhurst GP; Lee YH; Lambert G; Ward JM; Gonzalez FJ
    Mol Cell Biol; 2001 Feb; 21(4):1393-403. PubMed ID: 11158324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of hepatocyte nuclear factor 1 and 4 alpha (HNF1α and HNF4α) as a mechanism of arsenic carcinogenesis.
    Pastoret A; Marcos R; Sampayo-Reyes A; Saucedo-Cardenas O; Lozano-Garza GH; Hernandez A
    Arch Toxicol; 2013 Jun; 87(6):1001-12. PubMed ID: 23052196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The flavonoid derivative 4'-nitro-6-hydroxyflavone suppresses the activity of HNF4α and stimulates the degradation of HNF4α protein through the activation of AMPK.
    Inoue J; Ikeda S; Kanayama T; Sato R
    Biosci Biotechnol Biochem; 2017 Aug; 81(8):1548-1552. PubMed ID: 28475422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of Cholesterol Sulfotransferase SULT2B1b by Hepatocyte Nuclear Factor 4α Constitutes a Negative Feedback Control of Hepatic Gluconeogenesis.
    Bi Y; Shi X; Zhu J; Guan X; Garbacz WG; Huang Y; Gao L; Yan J; Xu M; Ren S; Ren S; Liu Y; Ma X; Li S; Xie W
    Mol Cell Biol; 2018 Apr; 38(7):. PubMed ID: 29378829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism.
    Xu Y; Zalzala M; Xu J; Li Y; Yin L; Zhang Y
    Nat Commun; 2015 Jun; 6():7466. PubMed ID: 26100857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism.
    Yang SH; Xu RX; Cui CJ; Wang Y; Du Y; Chen ZG; Yao YH; Ma CY; Zhu CG; Guo YL; Wu NQ; Sun J; Chen BX; Li JJ
    Cardiovasc Diabetol; 2018 Apr; 17(1):48. PubMed ID: 29618348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel findings of 18β-glycyrrhetinic acid on sRAGE secretion through inhibition of transient receptor potential canonical channels in high-glucose environment.
    Li ZY; Tung YT; Chen SY; Yen GC
    Biofactors; 2019 Jul; 45(4):607-615. PubMed ID: 31120605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. H19 lncRNA alters methylation and expression of Hnf4α in the liver of metformin-exposed fetuses.
    Deng J; Mueller M; Geng T; Shen Y; Liu Y; Hou P; Mamillapalli R; Taylor HS; Paidas M; Huang Y
    Cell Death Dis; 2017 Dec; 8(12):e3175. PubMed ID: 29215608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Underexpressed coactivators PGC1alpha and SRC1 impair hepatocyte nuclear factor 4 alpha function and promote dedifferentiation in human hepatoma cells.
    Martínez-Jiménez CP; Gómez-Lechón MJ; Castell JV; Jover R
    J Biol Chem; 2006 Oct; 281(40):29840-9. PubMed ID: 16891307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of class I histone deacetylase (HDAC) on gluconeogenesis in liver.
    Oiso H; Furukawa N; Suefuji M; Shimoda S; Ito A; Furumai R; Nakagawa J; Yoshida M; Nishino N; Araki E
    Biochem Biophys Res Commun; 2011 Jan; 404(1):166-72. PubMed ID: 21108932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FX5 as a non-steroidal GR antagonist improved glucose homeostasis in type 2 diabetic mice via GR/HNF4α/miR-122-5p pathway.
    Xu X; Chen Y; Zhu D; Zhao T; Xu R; Wang J; Hu L; Shen X
    Aging (Albany NY); 2020 Dec; 13(2):2436-2458. PubMed ID: 33316780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects.
    Wang X; Liu R; Zhang W; Zhang X; Liao N; Wang Z; Li W; Qin X; Hai C
    Mol Cell Endocrinol; 2013 Aug; 376(1-2):70-80. PubMed ID: 23791844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway.
    Wei S; Zhang M; Yu Y; Lan X; Yao F; Yan X; Chen L; Hatch GM
    PLoS One; 2016; 11(3):e0152097. PubMed ID: 27011261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
    Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
    J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice.
    Franko A; Neschen S; Rozman J; Rathkolb B; Aichler M; Feuchtinger A; Brachthäuser L; Neff F; Kovarova M; Wolf E; Fuchs H; Häring HU; Peter A; Hrabě de Angelis M
    Mol Metab; 2017 Mar; 6(3):256-266. PubMed ID: 28271032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liraglutide improves hepatic insulin resistance via the canonical Wnt signaling pathway.
    Qin Y; Chen M; Yang Y; Zhou XR; Shao SY; Wang DW; Yuan G
    Mol Med Rep; 2018 May; 17(5):7372-7380. PubMed ID: 29568881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.